Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

MEK1/2

MEK1/2, also known as MAPKK (mitogen-activated protein kinase kinase), is a kinase enzyme which phosphorylates MAPK (mitogen-activated protein kinase).

Items 21-30 of 37

Page
per page
  1. PD 184161
    C4361 PD 184161
    Summary: MEK1/2 inhibitor
      ≤10 mg/mL
  2. Refametinib
    B1267 Refametinib
    Target: MEK
    Summary: MEK 1/ MEK 2 inhibitor
      insoluble in H2O; ≥151.8 mg/mL
  3. GDC-0623
    B1135 GDC-0623
    Target: MEK
    Summary: MEK1 inhibitor, potent and ATP-uncompetitive
      insoluble in H2O; ≥16.85 mg/mL
  4. Arctigenin
    N2399 Arctigenin
    Summary: Anti-inflammatory, antiproliferative
      insoluble in H2O; insoluble in EtOH; ≥17.2 mg/mL
  5. U0124
    B6882 U0124
    Summary: Inactive analog of U0126(MEK-1/2 inhibitor), used as a negative control
      <22.63 mg/mL
  6. PD 198306
    B7124 PD 198306
    Summary: MEK1/2 inhibitor
      Soluble in DMSO
  7. 10Z-Hymenialdisine
    B5126 10Z-Hymenialdisine
    Summary: Pan kinase inhibitor
      Soluble in DMSO
  8. Vemurafenib (PLX4032, RG7204)
    A3004 Vemurafenib (PLX4032, RG7204)
     9 Citation
    Target: Raf
    Summary: BRAF kinase inhibitor
      ≥24.5 mg/mL
  9. PD0325901
    A3013 PD0325901
     5 Citation
    Summary: MEK inhibitor
      ≥24.1 mg/mL
  10. PLX-4720
    A3016 PLX-4720
     1 Citation
    Target: Raf
    Summary: BRAF kinase inhibitor
      ≥20.69 mg/mL

Items 21-30 of 37

Page
per page